SCM Lifescience Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 51
Employees
  • Stock Symbol
  • 298060
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $17.52
  • (As of Friday Closing)

SCM Lifescience General Information

Description

SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, stem cell products in South Korea.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Primary Office
  • 7-7, Gaetbeol-ro 145beon-gil
  • 7-28, Songdo-dong, Yeonsu-gu
  • Incheon, 21999
  • South Korea
+82 000-000-0000

SCM Lifescience Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SCM Lifescience Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.52 $17.51 $16.46 - $55.49 $209M 11.9M 54.1K -$0.31

SCM Lifescience Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 323,725 510,904
Revenue 345 271 145 26
EBITDA (4,762) (6,837) (32,941) (33,920)
Net Income (5,818) (8,159) (36,493) (36,479)
Total Assets 59,370 69,934 35,427 39,217
Total Debt 5,743 6,086 6,163 57,237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SCM Lifescience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SCM Lifescience‘s full profile, request access.

Request a free trial

SCM Lifescience Patents

SCM Lifescience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200384035-A1 Pharmaceutical composition for preventing or treating atopic dermatitis comprising clonal stem cells Pending 16-Jan-2019 000000000
EP-3480301-A1 Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof Pending 06-Nov-2017 0000000000 0
JP-2019083805-A Stem cell subfractionation culturing and proliferation methods Granted 06-Nov-2017 0000000000
US-20190136189-A1 Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof Pending 06-Nov-2017 0000000000
JP-6786554-B2 Stem cell layer separation culture and proliferation method Active 06-Nov-2017 C12N5/0654

SCM Lifescience Executive Team (8)

Name Title Board Seat Contact Info
Byung-Geon Rhee Ph.D Chief Executive Officer
Sung Woo Jeong Chief Financial Officer
Seok Woo Oh Chief Operating Officer & Vice President
Sun U. Song Ph.D Founder, Chief Scientific Officer & Vice President
Don Lee Manager of Business Development
You’re viewing 5 of 8 executive team members. Get the full list »

SCM Lifescience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SCM Lifescience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SCM Lifescience‘s full profile, request access.

Request a free trial

SCM Lifescience Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 23-Jun-2021 00000 00000 00 0000 Biotechnology
CoImmune 13-Feb-2019 Merger/Acquisition 000.00 Biotechnology 00000-0000 0000 00.0
To view SCM Lifescience’s complete investments and acquisitions history, request access »